Abstract
One of the most commonly used approaches for determining the quantity of infectious RSV particles in a given sample is the plaque assay. RSV infectious particles can be quantified by various direct and indirect methods. Here, we explain two simple methods for RSV titration: plaque assay and immunostaining assay.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Power UF et al (1997) Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology 230(2):155–166
Boyoglu-Barnum S et al (2015) An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. Virology 483:117–125
Haynes LM et al (2009) Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. J Infect Dis 200(3):439–447
McKimm-Breschkin JL (2004) A simplified plaque assay for respiratory syncytial virus--direct visualization of plaques without immunostaining. J Virol Methods 120(1):113–117
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Jorquera, P.A., Tripp, R.A. (2016). Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining Assay. In: Tripp, R., Jorquera, P. (eds) Human Respiratory Syncytial Virus. Methods in Molecular Biology, vol 1442. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3687-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3687-8_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3685-4
Online ISBN: 978-1-4939-3687-8
eBook Packages: Springer Protocols